Executives
-
Marucci Anthony SPRESIDENT & CEO -
Martin Samuel BatesSVP AND CFO
-
Crowley ElizabethSR. VP & CPDO
-
Jimenez Freddy A.SVP & GENERAL COUNSEL
-
Young Diane C.SVP, CHIEF MEDICAL OFFICER
-
Heath-Chiozzi MargoSVP OF REGULATORY AFFAIRS
-
Cavanaugh SarahSVP OF CORP AFFAIRS & ADMIN.
-
Wright Richard M.SR. VP & CCO
-
Pepin RonaldSR. VP & CBO
-
Keler TiborEXECUTIVE VP & CSO
?
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
Celldex Therapeutics, Inc.
US, Hampton [HQ]
CIK
1718112
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
13,383
Price per Share :
$22.62
Equivalence :
$302,723.46
Transaction History
-
M13,383 Shares After TransactionValue : $120,714.66$56,726.78Transaction Date : 06/03/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
-
M71,752 Shares After TransactionValue : $744,785.76$605,870.22Transaction Date : 06/03/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
-
S13,383 Shares After TransactionValue : $450,337.95Sold $1,964,116.85Transaction Date : 06/03/24
-
Footnotes
-
-
Footnotes:#1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.27 to $34.08 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
-
M41,162 Shares After TransactionValue : $114,430.36$80,809.04Transaction Date : 05/30/24
-
Footnotes
-
-
Footnotes:#1 Includes 847 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.850 to $34.445 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
-
M43,205 Shares After TransactionValue : $389,709.10$18,427.86Transaction Date : 05/30/24
-
Footnotes
-
-
Footnotes:#1 Includes 847 shares of common stock acquired under the Celldex Therapeutics, Inc. 2004 Employee Stock Purchase Plan.#2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.850 to $34.445 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.